The Latest Updates in Global GMP

This webinar will provide the latest GMP updates which are supported by the following health regulatory authorities: EMA, PIC/S, FDA, WHO, ANVISA, MHRA, etc. and will address all sections that will be revised in the GMP Guide. Concept papers, draft articles, and the latest developments in the International GMP Guidelines will also be discussed.

Many pharmaceutical manufacturers tend to describe GMP practices as the rules that personnel must comply with throughout production and the recording of production steps. However, GMP is a comprehensive set of rules in which the steps to be followed in all processes, including the production of pharmaceutical products and R&D activities throughout the product life cycle, are validated and recorded.

GMP disasters throughout history have caused indelible tragedies in many companies. Every country that considers patient health and safety as the priority allows the production, import, and sale of pharmaceutical products per the internationally recognised current GMP rules. GMP, regularly appears as cGMP (current Good Manufacturing Practices) and is encouraged and supported by the regulatory authorities who often remind the manufacturer that they must constantly stay up-to-date.

This webinar will provide an essential update on the latest changes and ensure you are cGMP ready.